Skip to content

Efficacy and Neural Mechanisms of HD-tDCS Priming iTBS Over the Contralesional Dorsal Premotor Cortex for Enhancing Upper Limb Motor Recovery After Stroke

Efficacy and Neural Mechanisms of HD-tDCS Priming iTBS Over the Contralesional Dorsal Premotor Cortex for Enhancing Upper Limb Motor Recovery After Stroke

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119646
Enrollment
Unknown
Registered
2026-03-02
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

HD-tDCD+iTBS Group:iTBS applied subsequent to cathodal HD-tDCS preconditioning
Sham Group:Sham iTBS applied subsequent to sham HD-tDCS preconditioning
Sham HD-tDCS+iTBS Group:iTBS applied subsequent to sham HD-tDCS preconditioning

Sponsors

Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with ischemic stroke by computed tomography and/or magnetic resonance imaging, meeting the diagnostic criteria for cerebral infarction. 2. First-ever, unilateral onset, or a history of prior stroke without residual neurological deficits. 3. Stable vital signs and clear consciousness. 4. Aged 40 to 70. 5. Disease duration of 1 week to 3 months. 6. Presence of upper limb paralysis. 7. Fulg-Meyer assessment upper extremity score <= 22. 8. The patient and their family voluntarily agree to participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. A history of epilepsy, a first-degree relative with idiopathic epilepsy, or current use of pro-convulsant medications. 2. Functional impairment or failure of major organs such as the heart, lungs, liver, or kidneys. 3. Severe cognitive or communication impairment that prevents cooperation with the study. 4. Posterior circulation infarction. 5. Presence of contraindications to TMS, including pacemakers, artificial metallic heart valves, drug-delivery pumps, insulin pumps, aneurysm clips (except titanium), or other metallic implants in the body. 6. Severe cervical spondylosis, such as marked cervical spinal canal stenosis or cervical instability. 7. Complete occlusion of the internal carotid artery. 8. Skull defects in the stimulation area. 9. Pregnant women. 10. Patients with high fever. 11. Patients with claustrophobia.

Design outcomes

Primary

MeasureTime frame
Fulg-Meyer assessment upper extremity score;

Secondary

MeasureTime frame
Magnetic resonance imaging;modified Barthel index;motricity index;Hong Kong edition of functional test for the hemiplegic upper extremity;safety evalution indicator;modified ashworth scale;

Countries

China

Contacts

Public ContactWenjun Dai

Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

njdaiwenjun@163.com+86 25 68303155

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026